MEMPHIS, Tenn., Feb. 16 /PRNewswire-FirstCall/ -- Smith & Nephew Orthopaedics announced today the appointment of Ken Reali to the role of Vice President and General Manager for the Clinical Therapies division. Ken will report to Mark Augusti, president of Orthopaedics Trauma and Clinical Therapies.
Ken is succeeding Joe Woody, who has been appointed President of Smith & Nephew Advanced Wound Management.
“Ken is an integral member of the Orthopaedics team. His extensive background in the medical device field, particularly within orthobiologics, has proven invaluable to the Clinical Therapies division,” said Mark Augusti, president of Smith & Nephew Orthopaedics Trauma and Clinical Therapies. “I am confident that Clinical Therapies will continue to grow and maintain its outstanding performance under Ken’s leadership.”
Reali, 40, most recently served as vice president of Marketing for the Clinical Therapies division, a role in which he was able to increase the division’s focus on both sales and product development. Reali has more than 15 years of experience in the medical device field. He joined Smith & Nephew in 2005 from Stryker Corporation, where he last served as vice president of Sales. He began his career at EBI Medical, where he worked with electrical bone stimulation.
Reali is a graduate of Valparaiso University in Valparaiso, Indiana.
Clinical Therapies
Smith & Nephew Orthopaedics’ Clinical Therapies markets the EXOGEN(TM) bone healing system and SUPARTZ(TM) joint fluid therapy. The Clinical Therapies business has grown considerably, 40% in the U.S. and 38% Globally in 2005.
About us
Smith & Nephew is a global medical technology business, specializing in Orthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephew ranks as the global leader in arthroscopy and one of the world’s leaders in advanced wound management and is one of the fastest growing orthopaedics companies in the world.
Smith & Nephew is dedicated to helping improve people’s lives. The company prides itself on the strength of its relationships with its surgeon and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The company has over 8,500 employees and operates in 33 countries around the world and generated annual sales of $2.6 billion.
Forward-Looking Statements
This press release contains certain “forward-looking statements” within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our operating margins discussed under “Outlook” are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases “aim,” “plan,” “intend,” “anticipate,” “well-placed,” “believe,” “estimate,” “expect,” “target,” “consider” and similar expressions, are generally intended to identify forward-looking statements. Such forward- looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew’s most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew’s expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Smith & Nephew Orthopaedics
CONTACT: Victor Rocha of Smith & Nephew Orthopaedics, +1-901-399-6771
Web site: http://www.smith-nephew.com//
